(Q37849615)

24 August 2017

1 reference

title

Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease (English)

1 reference

24 August 2017

0 references

0 references

1 reference

1

1 reference

PubMed ID

21373761

24 August 2017

language of work or name

1 reference

5 March 2011

1 reference

Journal of Neural Transmission

24 August 2017

1 reference

24 August 2017

118

1 reference

24 August 2017

5

1 reference

24 August 2017

747-752

1 reference

https://scigraph.springernature.com/pub.10.1007/s00702-011-0607-8

24 August 2017

0 references

cites work

Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

NOX activity is increased in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Monocyte/macrophage differentiation in early multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Role of mitochondrial dysfunction in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Protein co-expression with axonal injury in multiple sclerosis plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Convergence of amyloid-beta and tau pathologies on mitochondria in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Emerging multiple sclerosis disease-modifying therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

The effect of age on the non-haemin iron in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

The non-haemin iron in the cerebral cortex in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Systemic inflammation and disease progression in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Alzheimer's disease: Moving towards a vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Alzheimer 100--highlights in the history of Alzheimer research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Brain iron and ferritin in Parkinson's and Alzheimer's diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

The immunopathology of multiple sclerosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Mitochondrial defects in acute multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Mitochondrial changes within axons in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Oxidative damage is the earliest event in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

RNA oxidation in Alzheimer disease and related neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Microglia in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Activation of NADPH oxidase in Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Multiple sclerosis: an immune or neurodegenerative disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0607-8

Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease.

21 January 2018

1 reference

12 December 2020

Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4.

1 reference

12 December 2020

Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years

1 reference

12 December 2020

Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury.

1 reference

12 December 2020

Radical changes in multiple sclerosis pathogenesis

1 reference

12 December 2020

Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology

1 reference

12 December 2020

Multiple sclerosis and Alzheimer's disease

1 reference

12 December 2020

Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases

1 reference

12 December 2020

Peroxynitrite formation within the central nervous system in active multiple sclerosis

1 reference

12 December 2020

Mitochondria and the link between neuroinflammation and neurodegeneration

1 reference

12 December 2020

Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.

1 reference

12 December 2020

Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease

1 reference

12 December 2020

Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases.

1 reference

12 December 2020

Mitochondrial abnormalities in Alzheimer's disease.

1 reference

12 December 2020

10.1007/S00702-011-0607-8

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21373761